Open Navigation Menu To revist this article, visit My Profile, then View saved stories.
Close Alert Backchannel Business Culture Gear Ideas Science Security Merch To revist this article, visit My Profile, then View saved stories.
Close Alert Search Backchannel Business Culture Gear Ideas Science Security Merch Podcasts Video Artificial Intelligence Climate Games Newsletters Magazine Events Wired Insider Jobs Coupons Grace Huckins Science Without Code for DeepMindâ€™s Protein AI, This Lab Wrote Its Own Photograph: MirageC/Getty Images Save this story Save Save this story Save Company Alphabet End User Research Sector Health care Research Technology Machine learning Neural Network For biologists who study the structure of proteins, the recent history of their field is divided into two epochs: before CASP14 , the 14th biennial round of the Critical Assessment of Protein Structure conference, and after. In the decades before, scientists had spent years slowly chipping away at the problem of how to predict the structure of a protein from the sequence of amino acids that it comprises. After CASP14, which took place in December 2020, the problem had effectively been solved, by researchers at the Google subsidiary DeepMind.
A research company focused on a branch of artificial intelligence known as deep learning, DeepMind had previously made headlines by building an AI system that beat the Go world champion. But its success at protein structure prediction, which it achieved using a neural network called AlphaFold2, represented the first time it had built a model that could solve a problem of real scientific relevance. Helping scientists figure out what proteins look like can facilitate research into the inner workings of cells and, by revealing ways to inhibit the action of particular proteins, potentially aid in the process of drug discovery. On July 15, the journal Nature published an unedited manuscript detailing the workings of DeepMindâ€™s model, and DeepMind shared its code publicly.
But in the seven months since CASP, another team had taken up that mantle. In June, a full month before the publication of DeepMindâ€™s manuscript, a team led by David Baker, director of the Institute for Protein Design at the University of Washington, released their own model for protein structure prediction. For a month, this model, called RoseTTAFold, was the most successful protein prediction algorithm that other scientists could actually use. Though it did not reach the same peaks of performance as AlphaFold2, the team ensured the model would be accessible to even the least computationally inclined scientist by building a tool that allowed researchers to submit their amino acid sequences and get back predictions, without getting their hands dirty with computer code. A month later, on the very same day that Nature released the DeepMind early manuscript, the journal Science published the Baker labâ€™s paper describing RoseTTAFold.
Both RoseTTAFold and AlphaFold2 are complex, multilayered neural networks that output predicted 3D structures for a protein when given its amino acid sequence. And they share some interesting design similarities, like a â€œmultitrackâ€ structure that allows them to analyze different aspects of protein structure separately.
These similarities are no coincidenceâ€”the University of Washington team designed RoseTTAFold using ideas from the DeepMind teamâ€™s 30-minute presentation at CASP, in which they outlined the innovative elements of AlphaFold2. But they were also inspired by the uncertainty that followed that short talkâ€”at that point the DeepMind team had given no indication about when it would give scientists access to its unprecedented technology. Some researchers were worried that a private company might buck standard academic practice and keep its code from the broader community. â€œEveryone was floored, there was a lot of press, and then it was radio silence, basically,â€ says Baker. â€œYouâ€™re in this weird situation where thereâ€™s been this major advance in your field, but you canâ€™t build on it.â€ Baker and Minkyung Baek, a postdoctoral fellow in his lab, saw an opportunity. They might not have the code that the DeepMind team used to solve the protein structure problem, but they knew it could be done. And they also knew, in general terms, how DeepMind had done it. â€œEven at that point, David was saying, â€˜This is an existence proof. DeepMind has shown that these sorts of methods can work,â€™â€ says John Moult, a professor at the University of Maryland College Parkâ€™s Institute for Bioscience and Biotechnology Research and organizer of the CASP event. â€œThat was enough for him.â€ Culture Taylor Swift and BeyoncÃ© Are Resurrecting the American Movie Theater Angela Watercutter Gear The Best Home Depot Black Friday Deals Matt Jancer Gear Appleâ€™s Pledge to Support RCS Messaging Could Finally Kill SMS Boone Ashworth Business Swedenâ€™s Tesla Blockade Is Spreading Morgan Meaker With no knowledge of whenâ€”or ifâ€”the DeepMind team might make its tool available to the structural biologists who hoped to use it, Baker and Baek decided to try to build their own version.
Figuring out the three-dimensional structure of proteins is essential to understanding the inner workings of cells, says Janet Thornton, director emeritus of the European Bioinformatics Institute. â€œThe DNA codes for everything, but it doesnâ€™t really do anything,â€ she says. â€œItâ€™s the proteins that do all the work.â€ Scientists have used a variety of experimental techniques to try to figure out protein structure, but sometimes the data simply isnâ€™t informative enough to provide a clear answer.
A computer model that uses a proteinâ€™s unique sequence of amino acids to predict what it might look like can help researchers figure out what that confusing data means. For the past 27 years, CASP has given scientists a systematic way to evaluate the performance of their algorithms. â€œThe progress has been consistent, but rather slow,â€ Thornton says. But with AlphaFold2, she continues, â€œthe improvement was pretty dramaticâ€”more dramatic than weâ€™ve seen for many years, actually. And so in that respect, it was a step change.â€ The Baker lab had achieved the second-best performance at CASP14 with a model of its own, which gave them a solid place to start when it came to reproducing DeepMindâ€™s method. They systematically compared what DeepMind team members had said about AlphaFold2 to their own approach, and, once they had identified DeepMindâ€™s most important advances, worked on building them into a new model, one by one.
One crucial innovation they adopted was the idea of a multitrack network. Most neural network models process and analyze data along a single â€œtrack,â€ or path through the network, with successive layers of simulated â€œneuronsâ€ transforming the outputs of the previous layer. Itâ€™s a bit like the players in a game of telephone transforming the words they hear into the words they whisper into the ear of the person next to themâ€”only in a neural network, information is gradually rearranged into a more useful form, rather than degraded, like in the game.
DeepMind designed AlphaFold2 to segregate different aspects of protein structure information into two separate tracks that fed some information back to each otherâ€”like two separate games of telephone happening in parallel, with adjacent players passing some information back and forth. RoseTTAFold, Baker and Baek found, worked best with three.
Culture Taylor Swift and BeyoncÃ© Are Resurrecting the American Movie Theater Angela Watercutter Gear The Best Home Depot Black Friday Deals Matt Jancer Gear Appleâ€™s Pledge to Support RCS Messaging Could Finally Kill SMS Boone Ashworth Business Swedenâ€™s Tesla Blockade Is Spreading Morgan Meaker â€œWhen you draw some complicated figure, you donâ€™t draw it all at once,â€ Baek says. â€œYou will just start from very rough sketches, adding some pieces and adding some details step by step. Protein structure prediction is somewhat similar to this kind of process.â€ To see how RoseTTAFold worked in the real world, Baker and Baek reached out to structural biologists who had protein structure problems that they couldnâ€™t solve. At 7 pm one evening, David Agard, a professor of biochemistry and biophysics at UC San Francisco, sent them the amino acid sequence for a protein produced by bacteria infected with a particular virus. The structure predictions came back by 1 am. In six hours, RoseTTAFold had solved a problem that had bedeviled Agard for two years. â€œWe could actually see how it evolved from a combination of two bacterial enzymes, probably millions of years ago,â€ Agard says. Now past this bottleneck, Agard and his lab could move forward in figuring out how the protein worked.
Even though RoseTTAFold hadnâ€™t reached the same stratospheric level of performance as AlphaFold2, Baker and Baek knew then that it was time to release their tool into the world. â€œIt was still clearly very useful, because these people were solving biological problems that in many cases had been outstanding for quite a long time,â€ Baker says. â€œâ€‹â€‹We decided at that point, â€˜Well, itâ€™s good for the scientific community to know about this and have access to this.â€™â€ On June 15, they released the tool that allowed anyone to easily run their model, as well as a preprint of their forthcoming Science paper.
Unbeknownst to them, at DeepMind, an extensive scientific paper detailing its system was already under review at Nature , according to John Jumper, who leads the AlphaFold project. DeepMind had submitted its manuscript to Nature on May 11.
At that point, the scientific community knew little about DeepMindâ€™s timeline. That changed three days after Bakerâ€™s preprint became available, on June 18, when DeepMind CEO Demis Hassabis took to Twitter. â€œWeâ€™ve been heads down working flat out on our full methods paper (currently under review) with accompanying open source code and on providing broad free access to AlphaFold for the scientific community,â€ he wrote. â€œMore very soon!â€ Culture Taylor Swift and BeyoncÃ© Are Resurrecting the American Movie Theater Angela Watercutter Gear The Best Home Depot Black Friday Deals Matt Jancer Gear Appleâ€™s Pledge to Support RCS Messaging Could Finally Kill SMS Boone Ashworth Business Swedenâ€™s Tesla Blockade Is Spreading Morgan Meaker On July 15, the very same day that Bakerâ€™s RoseTTAFold paper was published, Nature released DeepMindâ€™s unedited but peer-reviewed AlphaFold2 manuscript.
 Simultaneously, DeepMind made the code for AlphaFold2 freely available on GitHub. And a week later, the team released an enormous database of 350,000 protein structures that had been predicted by its method. The revolutionary protein prediction tool, and a vast volume of its predictions, were at last in the hands of the scientific community.
According to Jumper, thereâ€™s a banal reason for why DeepMindâ€™s paper and code werenâ€™t released until more than seven months after the CASP presentation: â€œWe werenâ€™t ready to open source or put out this extremely detailed paper that day,â€ he says. Once the paper was submitted in May, and the team was working through the peer review process, Jumper says they tried to get the paper out as soon as possible. â€œWe had honestly been pushing as fast as we could,â€ he says.
The DeepMind teamâ€™s manuscript was published through Nature â€™s Accelerated Article Preview workflow, which the journal most frequently uses for Covid-19 papers. In a statement to WIRED, a spokesperson for Nature wrote that this process is intended â€œas a service to our authors and readers, in the interests of making particularly noteworthy and time-sensitive peer reviewed research available as quickly as possible.â€ Jumper and Pushmeet Kohli, lead of DeepMindâ€™s science team, demurred about whether Bakerâ€™s paper factored into the timing of their Nature publication. â€œFrom our perspective, we contributed and submitted the paper in May, and so it was out of our hands, in some sense,â€ Kohli says.
But CASP organizer Moult believes that the University of Washington teamâ€™s work may have helped DeepMind scientists convince their parent company to make their research freely available on a shorter timescale. â€œMy sense from knowing themâ€”they are really outstanding scientistsâ€”is that they would like to be as open as possible,â€ Moult says. â€œThere is some tension there, in that itâ€™s a commercial enterprise, and in the end itâ€™s got to make money somehow.â€ The company that owns DeepMind, Alphabet, has the fourth-highest market cap in the world.
Hassabis characterizes the release of AlphaFold2 as a benefit to both the scientific community and Alphabet. â€œThis is all open science, and weâ€™re giving this to humanity, no strings attachedâ€”the system, the code, and the database,â€ he said in an interview with WIRED. Asked whether there was any discussion about keeping the code private for commercial reasons, he said, â€œItâ€™s a good question how we deliver value. Value can be delivered in a lot of different ways, right? One is obviously commercial, but thereâ€™s also prestige.â€ Culture Taylor Swift and BeyoncÃ© Are Resurrecting the American Movie Theater Angela Watercutter Gear The Best Home Depot Black Friday Deals Matt Jancer Gear Appleâ€™s Pledge to Support RCS Messaging Could Finally Kill SMS Boone Ashworth Business Swedenâ€™s Tesla Blockade Is Spreading Morgan Meaker Baker is quick to praise the DeepMind team for the thoroughness of their paper and code release. In a sense, he says, RoseTTAFold was a hedge against the possibility that DeepMind would not act in the spirit of scientific collaboration. â€œIf they had been less enlightened and decided not to release the code, then there at least would have been a starting point for the world to build on,â€ he says.
That said, he feels that if the information had been released earlier, his team could have worked on pushing AlphaFold2 to perform even better or adapting it to the problem of designing artificial proteins, which is the Baker labâ€™s main focus. â€œThereâ€™s no doubt that if, say, in the beginning of December, after CASP, they had said, â€˜Hereâ€™s our code, and this is how we did it, we would be way, way further ahead,â€ Baker says.
And time could be of the essence for some of the real-world applications of protein structure prediction. Understanding the three-dimensional structure of a protein thatâ€™s essential to the survival of a pathogen could help scientists develop drugs to fight that pathogen, for instance. The applications could even extend to the pandemic; for example, DeepMind used a version of AlphaFold2 to predict the structures of some SARS-CoV-2 proteins last August.
Baker thinks that questions about information sharing between academia and industry will only grow more pressing. Problems in artificial intelligence require enormous time and resources to solve, and companies like DeepMind have access to personnel and computing power on a scale unimaginable for a university lab. â€œItâ€™s almost certain that the major advances will continue to be made at companies, and I think this will only accelerate,â€ Baker says. â€œThereâ€™s going to be internal pressure at those companies about whether to make the advances public, like DeepMind did here, or to try to monetize them.â€ Additional reporting by Will Knight.
Update 8-20-2021 5:48 PM ET: This story was updated to correct the length of DeepMind's CASP presentation.
ğŸ“© The latest on tech, science, and more: Get our newsletters ! A people's history of Black Twitter Why even the fastest human can't outrun your house cat Phantom warships are courting chaos in conflict zones This new way to train AI could curb online harassment How to build a solar-powered oven ğŸ‘ï¸ Explore AI like never before with our new database ğŸ® WIRED Games: Get the latest tips, reviews, and more ğŸƒğŸ½â€â™€ï¸ Want the best tools to get healthy? Check out our Gear teamâ€™s picks for the best fitness trackers , running gear (including shoes and socks ), and best headphones Topics artificial intelligence deep learning neural networks biotech Genomics genetics diseases Ben Brubaker Max G. Levy Elizabeth Finkel Celia Ford Maryn McKenna Matt Simon Erica Kasper Swapna Krishna Facebook X Pinterest YouTube Instagram Tiktok More From WIRED Subscribe Newsletters Mattresses Reviews FAQ Wired Staff Coupons Black Friday Editorial Standards Archive Contact Advertise Contact Us Customer Care Jobs Press Center RSS Accessibility Help CondÃ© Nast Store Do Not Sell My Personal Info Â© 2023 CondÃ© Nast. All rights reserved. Use of this site constitutes acceptance of our User Agreement and Privacy Policy and Cookie Statement and Your California Privacy Rights.
WIRED may earn a portion of sales from products that are purchased through our site as part of our Affiliate Partnerships with retailers. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of CondÃ© Nast.
Ad Choices Select international site United States LargeChevron UK Italia JapÃ³n Czech Republic & Slovakia
